- E-mail : info@wellonapharma.com
- Call : +91-261-2571244
- Mob: +91-7490041245
Rizatriptan is FDA-approved to treat acute migraine attacks with or without aura. It does not prevent future migraine attacks. Rizatriptan is also used off-label to treat cluster headaches.
Specification:
|
Item |
Specification |
|
Content(dry base) |
99.0-11.5% |
|
Loss on dry |
≤2.0% |
|
Chloride |
≤0.02% |
|
Chloride-containing compounds |
≤0.03% |
|
Heavy metals |
≤0.001% |
|
Arsenic(AS) |
≤0.0002% |
|
Sulfate |
≤0.1% |
Packaging details:
|
Packaging details: |
25kg/drum with double plastic bags inside; packed in a cardboard drum or fiber HDPE drum. |
|
Storage: |
Stored in a clean, cool, dry area; keep away from moisture and strong, direct light/heat |
|
Shelf Life: |
5 years if sealed and store away from direct sun light. |
